Australian testing services provider ALS Ltd rejected an A$2.67 billion ($1.93 billion) takeover proposal from private equity firms Advent International and Bain Capital, saying its board felt the offer significantly undervalued the company.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
